Immunocytochemical expression of E-cadherin on fine-needle aspirates from breast carcinomas correlate with the cell dissociation pattern seen on smears

Diagnostic Cytopathology

Volumn 25, Issue 6, 2001, Pages 382-388

  Sauer, Torill ^a,b   Boudjema, Ghania ^a   Jebsen, Peter W ^a   Nss, Oddvar ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aberrant nuclear expression; Breast carcinoma; Cytological grading; E cadherin; Fine needle aspirates

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; UVOMORULIN;

ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CELL ADHESION; CELL NUCLEUS; CONTROLLED STUDY; DISSOCIATION; GIEMSA STAIN; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTRADUCTAL CARCINOMA; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CADHERINS; CARCINOMA; CELL ADHESION; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM RECURRENCE, LOCAL;

EID: 0035186670     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10030     Document Type: Article

References (30)

1. Functional correlations between cell adhesive properties and some cell surface proteins
2. Morphogenetic roles of classic cadherins
3. Cadherin expression in carcinomas: Role in the formation of cell junctions and prevention of invasiveness
4. Cadherin dysfunction in a human cancer cell line: Possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness
5. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
6. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinoma
7. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer
8. Recent advances in the genetics of metastasis
9. Altered expression of E-cadherin in breast cancer: Patterns, mechanisms and clinical significance
10. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma
11. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer
12. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas
13. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
14. Aspiration biopsy smear pattern as a predictor of biologic behavior in adenocarcinoma of the breast
15. A morphometric expression of differentiation in fine-needle biopsies of breast cancer
16. Predicting breast cancer recurrence
17. Image cytometry in malignancy grading of breast cancer. Results in a prospective study with seven years follow-up
18. Intercellular adhesion molecule expression in ductal carcinoma of the breast: Correlation of immunohistochemical staining with cytological smear pattern
19. Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas
20. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas
21. Nuclear localization of E-cadherin expression in Merkel cell carcinoma
22. Reciprocity between membranous and nuclear expression of B-catenin in colorectal tumours
23. Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of B-catenin mutations in synovial sarcoma
24. Expression of E-cadherin and catenins in invasive mammary carcinomas
25. Downregulation and abnormal expression of E-cadherin and β-catenin in nasopharyngeal carcinoma: Close association with advanced disease stage and lymph node metastasis
26. Cadherin-catenin expression in primary colorectal cancer: A survival analysis
27. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
28. Invasion promotor versus invasion suppressor molecules: The paradigm of E-cadherin
29. E-cadherin (E-cad) expression in ductal carcinoma in situ (DCIS) of the breast
30. E-cadherin quantitative immunocytochemical assays in breast carcinomas